Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis
Open Access
- 1 December 1999
- journal article
- case report
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 58 (12) , 770-772
- https://doi.org/10.1136/ard.58.12.770
Abstract
OBJECTIVE To assess factors associated with a poor outcome in rheumatoid arthritis (RA), a measure was developed of limited joint motion and deformity, a deformity index (DI), and correlated biochemical and genetic variables with the magnitude of the DI. METHODS Forty patients were evaluated in a cross sectional study. Clinical measures included the DI and Health Assessment Questionnaire, and disease variables included the erythrocyte sedimentation rate, C reactive protein, rheumatoid factor, and HLA-DRB1 and DQB1 alleles. RESULTS Significant correlations were noted between increasing DI and duration of RA and concentration of C reactive protein. Patients with a DQB1*301 allele or DR4 allele had a higher DI than those without, and a positive trend was noted between increasing DI and dose of DRB1 RA susceptibility alleles. The trend was lost when a non-linear regression technique was used to remove the effect attributable to C reactive protein, suggesting an interrelation between persistent inflammation and genetics in determining total joint damage. CONCLUSIONS The DI may be useful to study interactions between genetic and inflammatory processes in rheumatoid disease progression.Keywords
This publication has 14 references indexed in Scilit:
- Identification and Characterization of a Pro-tumor Necrosis Factor-α-processing Enzyme from the ADAM Family of Zinc MetalloproteasesJournal of Biological Chemistry, 1997
- Expression of Members of the Novel Membrane Linked Metalloproteinase Family ADAM in Cells Derived from a Range of Haematological MalignanciesBiochemical and Biophysical Research Communications, 1997
- Purification of ADAM 10 from bovine spleen as a TNFα convertaseFEBS Letters, 1997
- Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.Thorax, 1994
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- Similar frequency of autoantibodies against pneumocytes type II and Clara cells in patients with interstitial lung diseases and healthy personsJournal of Molecular Medicine, 1991
- A novel metalloproteinase originally isolated from brain myelin membranes is present in many tissuesBiochemical Journal, 1990
- Fine structural changes in cryptogenic fibrosing alveolitis and asbestosisThe Journal of Pathology, 1985
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984
- Circulating Immune Complexes in the Idiopathic Interstitial PneumoniasNew England Journal of Medicine, 1978